Recently, KornnacCaps achieved another significant milestone in its international strategic layout. The company successfully completed the production and shipment of a batch of Size 4 enteric-coated capsules, which were smoothly delivered to a client in Saudi Arabia. The successful conclusion of this export transaction not only marks the recognition of KornnacCaps' high-quality pharmaceutical excipients by the Middle Eastern market but also lays a solid foundation for the company to further expand into markets along the Belt and Road.
As one of the largest pharmaceutical consumer markets in the Middle East, Saudi Arabia maintains extremely strict quality standards and regulatory requirements for the import of drugs and excipients. The Size 4 enteric-coated capsules involved in this order are key excipients in pharmaceutical production, favored for their small size and ease of swallowing, and are commonly used for drugs that irritate the gastrointestinal tract or require release in specific sections of the intestine. To ensure the product perfectly matched the client's needs, KornnacCaps executed the highest standards across every stage, from raw material selection and production processes to finished product testing.
Upon receiving the order, the KornnacCaps production team responded promptly, formulating a comprehensive production plan tailored to the specific characteristics of enteric capsules. Due to their smaller size, Size 4 capsules present relatively higher technical difficulties in capsule forming and enteric coating processes. Relying on the company's modern intelligent production workshops and advanced coating technology, we precisely controlled the disintegration time and dissolution rate of the capsules. This ensures that every capsule remains intact in the gastric acid environment and smoothly enters the intestines to release the medicinal effect with precision. Simultaneously, the Quality Management Department strictly followed pharmacopoeia standards, conducting comprehensive physicochemical indicator tests on the products to ensure all batches complied with export standards.
The successful shipment to Saudi Arabia serves as another important milestone in KornnacCaps's expansion into international markets. This not only reflects the client's high trust in the quality of KornnacCaps products but also demonstrates the company's competitiveness within the global supply chain for pharmaceutical empty capsules. With the rapid development of the pharmaceutical industry in the Middle East, KornnacCaps will continue to cultivate this regional market, aiding local pharmaceutical enterprises in improving drug quality through superior products and professional services.
Looking ahead, KornnacCaps will continue to uphold the philosophy of Safety, Purity, and Innovation, strictly abide by international quality norms, and continuously optimize production processes. We are dedicated to providing global clients with superior empty capsule solutions and promoting Intelligent Manufacturing from China to the world stage.
